Skip to main content

Table 4 Differences in rs12696304 and rs2736100 genotyping between controls and patients with ESRD

From: The telomerase gene polymorphisms, but not telomere length, increase susceptibility to primary glomerulonephritis/end stage renal diseases in females

Patients

(M + F)

Odds ratio

(95% CI)

P value

Controls

(M only)

Patients

(M only)

Odds ratio

(95% CI)

P value

Controls

(F only)

Patients

(F only)

Odds ratio

(95% CI)

P

value

516 (100%)

  

289 (100%)

300 (100%)

  

226 (100%)

216 (100%)

  

51 (9.9)

1.0 (ref.)

 

32 (11.1)

31 (10.3)

1.0 (ref.)

 

24 (10.6)

20 (9.3)

1.0 (ref.)

 

186 (36.0)

0.916 (0.598–1.403)

0.686

119 (41.2)

108 (36.0)

0.937 (0.536–1.637)

0.819

104 (46.0)

78 (36.1)

0.900(0.464–1.745)

0.755

279 (54.1)

1.298 (0.855–1.970)

0.219

138 (47.7)

161 (53.7)

1.204 (0.699–2.074)

0.502

98 (43.4)

118 (54.6)

1.445 (0.753–2.771)

0.266

237 (45.9)

1.0 (ref.)

 

151 (52.3)

139 (46.3)

1.0 (ref.)

 

128 (56.6)

98 (45.4)

1.0 (ref.)

 

279 (54.1)

1.392 (1.089–1.778)

0.010

138 (47.7)

161 (53.7)

1.267 (0.917–1.752)

0.176

98 (43.4)

118 (54.6)

1.573 (1.080–2.289)

0.023

288 (27.9)

1.0 (ref.)

 

183 (31.7)

170 (28.3)

1.0 (ref.)

 

152 (33.6)

118 (27.3)

1.0 (ref.)

 

744 (72.1)

1.245 (1.031–1.503)

0.022

395 (68.3)

430 (71.7)

1.172 (0.913–1.504)

0.213

300 (66.4)

314 (72.7)

1.348 (1.011–1.798)

0.042

520 (100%)

  

289 (100%)

297 (100%)

  

226 (100%)

223 (100%)

  

156 (30.0)

1.0 (ref.)

 

93 (32.2)

104 (35.0)

1.0 (ref.)

 

65 (28.8)

52 (23.3)

1.0 (ref.)

 

248 (47.7)

0.977 (0.737–1.295)

0.873

136 (47.1)

134 (45.1)

0.881 (0.610–1.273)

0.500

121 (53.5)

114 (51.1)

1.178 (0.754–1.839)

0.472

116 (22.3)

1.175 (0.830–1.662)

0.363

60 (20.7)

59 (19.9)

0.879 (0.558–1.387)

0.580

40 (17.7)

57 (25.6)

1.781 (1.033–3.070)

0.037

560 (53.8)

1.0 (ref.)

 

322 (55.7)

342 (57.6)

1.0 (ref.)

 

251 (55.5)

218 (48.9)

1.0 (ref.)

 

480 (46.2)

1.075 (0.904–1.278)

0.415

256 (44.3)

252 (42.4)

0.927 (0.736–1.168)

0.519

201 (44.5)

228 (51.1)

1.306 (1.005–1.698)

0.046

  1. ESRD End-stage renal disease, M male, F female, CI confidence interval; italic P value: statistically significant